Pear Therapeutics- Warrants (01/12/2026) Overview

Pear Therapeutics- Warrants (01/12/2026) Other Income Expense Net

Other Income/Expense Net for PEARW.

Quarterly Other Income/Expense

$2.79M

↑ 109.02% YoY

As of Dec 31, 2022

Annual Other Income/Expense (TTM)

$47.86M

↑ 256.78% YoY

Trailing 12 months ending Dec 31, 2022

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin